Kayne Anderson Rudnick Investment Management’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-7
| Closed | -$373 | – | 971 |
|
|
2023
Q4 | $373 | Hold |
7
| – | – | ﹤0.01% | 903 |
|
|
2023
Q3 | $348 | Sell |
7
-461
| -99% | -$25.8K | ﹤0.01% | 816 |
|
|
2023
Q2 | $27.9K | Sell |
468
-1,118
| -70% | -$63.7K | ﹤0.01% | 536 |
|
|
2023
Q1 | $89.8K | Sell |
1,586
-6,183,580
| -100% | -$397M | ﹤0.01% | 457 |
|
|
2022
Q4 | $459M | Buy |
6,185,166
+1,629,455
| +36% | +$111M | 1.43% | 14 |
|
|
2022
Q3 | $271M | Sell |
4,555,711
-7,019
| -0.2% | -$423K | 0.9% | 37 |
|
|
2022
Q2 | $256M | Buy |
4,562,730
+2,542,264
| +126% | +$167M | 0.81% | 47 |
|
|
2022
Q1 | $149M | Buy |
2,020,466
+485,551
| +32% | +$33.8M | 0.4% | 80 |
|
|
2021
Q4 | $111M | Sell |
1,534,915
-12,690
| -0.8% | -$921K | 0.26% | 108 |
|
|
2021
Q3 | $119M | Buy |
1,547,605
+278,833
| +22% | +$22.4M | 0.29% | 100 |
|
|
2021
Q2 | $98.4M | Buy |
1,268,772
+249,884
| +25% | +$17.8M | 0.24% | 106 |
|
|
2021
Q1 | $62.8M | Buy |
1,018,888
+71,683
| +8% | +$4.54M | 0.17% | 126 |
|
|
2020
Q4 | $61.8M | Buy |
947,205
+61,370
| +7% | +$3.53M | 0.18% | 125 |
|
|
2020
Q3 | $43.9M | Buy |
885,835
+80,533
| +10% | +$4.15M | 0.16% | 128 |
|
|
2020
Q2 | $37.8M | Buy |
805,302
+114,287
| +17% | +$5.51M | 0.16% | 125 |
|
|
2020
Q1 | $29.4M | Buy |
691,015
+38,082
| +6% | +$1.88M | 0.17% | 114 |
|
|
2019
Q4 | $38.4M | Buy |
652,933
+65,741
| +11% | +$3.57M | 0.19% | 109 |
|
|
2019
Q3 | $30M | Buy |
587,192
+34,031
| +6% | +$1.62M | 0.16% | 112 |
|
|
2019
Q2 | $23.4M | Buy |
553,161
+71,718
| +15% | +$3.11M | 0.12% | 123 |
|
|
2019
Q1 | $23.8M | Buy |
481,443
+55,332
| +13% | +$2.5M | 0.14% | 116 |
|
|
2018
Q4 | $18.4M | Buy |
426,111
+86,776
| +26% | +$4.33M | 0.13% | 117 |
|
|
2018
Q3 | $19.3M | Buy |
339,335
+53,957
| +19% | +$2.84M | 0.11% | 133 |
|
|
2018
Q2 | $14.4M | Buy |
285,378
+48,624
| +21% | +$2.54M | 0.09% | 146 |
|
|
2018
Q1 | $11.8M | Sell |
236,754
-17,239
| -7% | -$810K | 0.09% | 159 |
|
|
2017
Q4 | $10.4M | Buy |
253,993
+4,585
| +2% | +$161K | 0.08% | 174 |
|
|
2017
Q3 | $7.41M | Buy |
249,408
+7,487
| +3% | +$229K | 0.07% | 181 |
|
|
2017
Q2 | $8.02M | Buy |
241,921
+20,910
| +9% | +$657K | 0.08% | 182 |
|
|
2017
Q1 | $6.55M | Buy |
221,011
+41,284
| +23% | +$1.13M | 0.07% | 184 |
|
|
2016
Q4 | $4.46M | Buy |
179,727
+80,362
| +81% | +$1.83M | 0.05% | 202 |
|
|
2016
Q3 | $2.24M | Buy |
99,365
+8,569
| +9% | +$201K | 0.03% | 239 |
|
|
2016
Q2 | $2.16M | Buy |
90,796
+16,082
| +22% | +$386K | 0.03% | 228 |
|
|
2016
Q1 | $1.77M | Buy |
74,714
+35,153
| +89% | +$859K | 0.03% | 236 |
|
|
2015
Q4 | $1.1M | Buy |
+39,561
| New | +$993K | 0.02% | 265 |
|
Other funds holding GMED
CIP
CCM
BAM
HRCM
Kayne Anderson Rudnick Investment Management's GMED Position: Q1 2024 in Review
Kayne Anderson Rudnick Investment Management sold out of Globus Medical (GMED) in Q1 2024, closing a stake of 7 shares — an estimated $373 sold.
Kayne Anderson Rudnick Investment Management first reported a position in GMED in Q4 2015 and held it in 33 quarters. The position peaked at $459M in Q4 2022. 439 funds tracked by Wall St. Rank hold GMED as of Q1 2024.
- Kayne Anderson Rudnick Investment Management reported no remaining Globus Medical position as of Q1 2024 after selling out during the quarter.
- Kayne Anderson Rudnick Investment Management sold 7 Globus Medical shares in Q1 2024, an estimated $373.
- Kayne Anderson Rudnick Investment Management first reported a position in Globus Medical in Q4 2015 and held it in 33 quarters.
- Kayne Anderson Rudnick Investment Management's Globus Medical position peaked at $459M in Q4 2022.
- 439 funds tracked by Wall St. Rank held Globus Medical as of Q1 2024.
Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2024, filed 14 May 2024.